Why you're still hungry on Mounjaro 2.5mg — and what to expect next

Step 1: understand what the 2.5mg pen is actually doing

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that together signal fullness, slow how quickly food leaves your stomach, and help regulate blood sugar. It is the only dual-agonist weight-loss medicine licensed in the UK. But those signals strengthen with dose. At 2.5mg, your system is still learning to tolerate the medicine: the priority is keeping side effects manageable, not suppressing your appetite to a meaningful degree.

Think of it this way: the first pen's job is adjustment. The nausea, fatigue, or digestive changes some people notice at this stage are the body responding to a new mechanism, not a malfunction. Hunger staying roughly where it was is expected. The full Mounjaro treatment overview covers how the dose ladder works across all six strengths.

One thing our prescribers hear regularly: people who feel no different at 2.5mg worry the medicine won't work for them. The evidence says otherwise, the appetite effect is dose-dependent, and it arrives.

Step 2: what changes as the dose increases from 2.5mg

The licensed UK dose schedule starts at 2.5mg and typically steps up in 4-week increments (2.5mg, 5mg, 7.5mg, and so on, up to 15mg) with each increase decided by your prescriber based on tolerability and response. Hunger reduction tends to become noticeable from 5mg onwards for most people, with further appetite suppression reported at each subsequent step.

In the SURMOUNT-1 trial, which randomised 2,539 adults with obesity, participants on the highest dose achieved around 20–21% average body-weight reduction over 72 weeks, a result that reflects months of titration, not the starting pen. Reviewing what the 5mg dose involves can help set realistic expectations for the next stage of treatment. If you are still hungry after several weeks at 2.5mg and wondering whether that's usual, the short answer is yes, and the right next step is a conversation with your prescriber about timing your first increase.

Your prescriber, not the leaflet, decides when you move up. That conversation matters more than the calendar.

Step 3: practical things that help while you wait for the dose to work

Hunger at 2.5mg doesn't mean you're helpless. A few evidence-consistent approaches sit alongside the medicine without overriding clinical guidance. Protein at every meal takes longer to digest and prolongs the fullness signal; it also protects muscle during weight loss, which matters because tirzepatide can reduce overall intake significantly once it's at therapeutic strength. Fibre (vegetables, pulses, wholegrains) adds bulk without many calories and slows gastric emptying in its own right.

Hydration is worth checking too. Thirst is frequently misread as hunger, and staying well hydrated supports both appetite regulation and kidney function, which the NHS tirzepatide guidance notes as a general principle alongside treatment. The detailed guide to managing hunger feelings at the 2.5mg stage covers portion patterns and meal timing in more depth.

Strength exercise also helps here. It preserves lean mass, improves insulin sensitivity, and (practically) gives the day some structure that isn't food-focused. None of this replaces titration, but it makes the waiting period more productive.

Step 4: when to talk to your prescriber about what comes next

If you are four weeks into 2.5mg and still finding hunger unchanged, that is the normal trigger point for your prescriber to review your dose. The question isn't whether you should say something (you absolutely should) it is making sure the review happens on time and with accurate information about how you've been getting on.

At nume, every repeat order goes through a clinical re-review before anything is dispatched. A real prescriber reads your update, not a checklist. If you're thinking about what treatment through a private online pharmacy involves, the treatment options page walks through the consultation process and what's included. For those already on the next rung and still finding hunger persistent, the experience of hunger at 5mg and what drives it is covered separately.

You can also report any unexpected effects during treatment using the MHRA Yellow Card scheme, it's open to patients as well as clinicians. If you have ever looked closely at your pen and wondered whether you have the right volume of 2.5mg Mounjaro in the cartridge, that page explains exactly what to expect.